These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7962474)
1. Non-competitive anti-oestrogenic activity of progesterone antagonists in primate models. Hodgen GD; van Uem JF; Chillik CF; Danforth DR; Wolf JP; Neulen J; Williams RF; Chwalisz K Hum Reprod; 1994 Jun; 9 Suppl 1():77-81. PubMed ID: 7962474 [TBL] [Abstract][Full Text] [Related]
2. Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms. Neulen J; Williams RF; Breckwoldt M; Chwalisz K; Baulieu EE; Hodgen GD Hum Reprod; 1996 Jul; 11(7):1533-7. PubMed ID: 8671500 [TBL] [Abstract][Full Text] [Related]
3. Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys. Wolf JP; Hsiu JG; Anderson TL; Ulmann A; Baulieu EE; Hodgen GD Fertil Steril; 1989 Dec; 52(6):1055-60. PubMed ID: 2591563 [TBL] [Abstract][Full Text] [Related]
4. Oestrogen action in the endometrium and oviduct of rhesus monkeys during RU486 treatment. Brenner RM; Slayden OD Hum Reprod; 1994 Jun; 9 Suppl 1():82-97. PubMed ID: 7962475 [TBL] [Abstract][Full Text] [Related]
5. Endometrial effects of RU486 in primates--antiproliferative action despite signs of estrogen action and increased cyclin-B expression. Heikinheimo O; Hsiu JG; Gordon K; Kim S; Williams RF; Gibbons WE; Hodgen GD J Steroid Biochem Mol Biol; 1996 Oct; 59(2):179-90. PubMed ID: 9010333 [TBL] [Abstract][Full Text] [Related]
6. Modulation of oestrogenic effects by progesterone antagonists in the rat uterus. Chwalisz K; Stöckemann K; Fritzemeier KH; Fuhrmann U Hum Reprod Update; 1998; 4(5):570-83. PubMed ID: 10027611 [TBL] [Abstract][Full Text] [Related]
7. Effects of a single post-ovulatory dose of RU486 on endometrial maturation in the implantation phase. Gemzell-Danielsson K; Svalander P; Swahn ML; Johannisson E; Bygdeman M Hum Reprod; 1994 Dec; 9(12):2398-404. PubMed ID: 7714164 [TBL] [Abstract][Full Text] [Related]
8. The antiprogestins RU486 and ZK98299 affect follicle-stimulating hormone secretion differentially on estrus, but not on proestrus. Ringstrom SJ; Szabo M; Kilen SM; Saberi S; Knox KL; Schwartz NB Endocrinology; 1997 Jun; 138(6):2286-90. PubMed ID: 9165013 [TBL] [Abstract][Full Text] [Related]
9. Morphologic response of endometrium to a progesterone receptor antagonist, RU486, in monkeys. Koering MJ; Healy DL; Hodgen GD Fertil Steril; 1986 Feb; 45(2):280-7. PubMed ID: 3949027 [TBL] [Abstract][Full Text] [Related]
11. The effects of the antiprogesterone RU486 (Mifepristone) on an endometrial secretory glycan: an immunocytochemical study. Graham RA; Li TC; Seif MW; Aplin JD; Cooke ID Fertil Steril; 1991 Jun; 55(6):1132-6. PubMed ID: 1709886 [TBL] [Abstract][Full Text] [Related]
12. The possible use of antiprogestins for contraception. Bygdeman M; Danielsson KG; Swahn ML Acta Obstet Gynecol Scand Suppl; 1997; 164():75-7. PubMed ID: 9225644 [TBL] [Abstract][Full Text] [Related]
13. Hypothalamo-pituitary effects of RU486: inhibition of progesterone-induced hyperprolactinaemia. Williams RF; Gordon K; Fung H; Kolm P; Hodgen GD Hum Reprod; 1994 Jun; 9 Suppl 1():63-8. PubMed ID: 7962471 [TBL] [Abstract][Full Text] [Related]
14. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle. Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438 [TBL] [Abstract][Full Text] [Related]
15. Ovary mediates the effects of RU486 given during proestrus on the diestrous secretion of luteinizing hormone in the rat. Tébar M; Ruíz A; Bellido C; Sánchez-Criado JE Biol Reprod; 1996 Jun; 54(6):1266-70. PubMed ID: 8724354 [TBL] [Abstract][Full Text] [Related]
16. Antiprogestins suppress basal and activin-stimulated follicle-stimulating hormone secretion in an estrogen-dependent manner. Szabo M; Kilen SM; Saberi S; Ringstrom SJ; Schwartz NB Endocrinology; 1998 May; 139(5):2223-8. PubMed ID: 9564826 [TBL] [Abstract][Full Text] [Related]
17. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486. Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550 [TBL] [Abstract][Full Text] [Related]